The 3 Small CRISPR Biotechs That Could Cure 10,000 Diseases Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three small biotech companies that appear to be leading the CRISPR race. Source: BioSpace You Might Also Like Telix Pharma, Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer January 18, 2017 Boehringer Ingelheim Partners With Provides Over Half A Million Dollars In Product Aid To Pets Affected By Hurricanes Harvey And Irma September 25, 2017 Oventus Extension Of Share Purchase Plan July 13, 2017
Telix Pharma, Release: Companies Conclude Therapeutic Product Development Agreement For Prostate Cancer January 18, 2017
Boehringer Ingelheim Partners With Provides Over Half A Million Dollars In Product Aid To Pets Affected By Hurricanes Harvey And Irma September 25, 2017
